Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Scalp cooling is a type of therapy that might reduce hair loss caused by chemotherapy (also known as chemotherapy-induced alopecia or CIA). You might also hear the medical term scalp hypothermia.
Scalp cooling (or scalp hypothermia) refers to lowering the temperature of the scalp with a scalp cooling device. For some people, scalp cooling might reduce hair loss caused by chemotherapy.
There are two main types of scalp cooling devices: automated and manual.
You might hear people call all of these devices “scalp cooling caps” or “cold caps”. But the two types of devices work in different ways. It’s important to understand the differences before you decide to use one.
Cooling caps (or cold caps) are automated scalp cooling systems regulated by the FDA.
They work by connecting a special cap to an automated device that circulates a liquid or gel cooled to a specific temperature. Automated cold caps are only approved for chemo-induced hair loss related to solid tumor cancers, not blood cancers.
There are currently three automated scalp cooling systems that are FDA-approved for preventing chemo-induced hair loss (alopecia).
Frozen gel caps are manual scalp cooling devices not regulated by the FDA.
This type of device doesn’t use an automated cooling system. Instead, it is manually cooled in a freezer or with dry ice. The temperature for frozen gel caps must be much lower compared to automated cold cap systems. This is because the cap starts to warm as soon as you put it on your head. You also need to switch to a new frozen cap every 30 minutes.
Frozen gel caps are not regulated by the FDA. Compared to automated scalp cooling systems, frozen gel caps are less expensive. But since they aren’t FDA approved, they are less likely to be covered or reimbursed by insurance.
Cold restricts blood flow. When you cool your scalp, you temporarily decrease blood flow to that area. This reduces the amount of chemo that gets to your hair follicle cells. For some people, protecting hair follicle cells from being damaged or killed by chemo can prevent or reduce scalp hair loss.
Scalp cooling does not prevent hair loss or thinning caused by immunotherapy and targeted drug therapy. This is because these treatments don’t work in the same way as chemo. However, chemo is more likely to cause hair loss compared to most immunotherapy and targeted drug therapy.
Cold caps and other scalp cooling devices aren’t recommended for everyone. It depends on several factors, including the type of cancer you have.
Scalp cooling is not recommended for people who:
Scalp cooling might not be as effective for people with:
Scalp cooling also isn’t recommended for pediatric patients. It has not been well studied or approved in children under 18 years of age.
Each person responds to scalp cooling differently. These devices work better for certain types or doses of chemo. For example, if a chemo regimen includes an anthracycline (like doxorubicin), scalp cooling might not work as well for reducing or preventing hair loss.
Some research also suggests that scalp cooling to prevent hair loss might not work as well for people with a thicker hair layer (compared to people with a thinner layer of hair). This could be because thicker hair insulates the scalp, preventing it from cooling down enough.
Research also suggests that the fit of a cooling cap is important. Cooling caps that aren’t fitted tightly have been linked with more hair loss. Increased hair loss often happens in patches where the cap’s contact with the scalp is poor.
Scalp cooling side effects are rare and usually tolerable. The most common side effects reported include:
There are a small number of reports of scalp thermal injury happening when people use the nonregulated manual cold caps. Some people use an inner cap or band to reduce the risk of thermal injury.
Cooling caps work by reducing the amount of chemo that gets to the hair follicle cells on the scalp. Some people ask if this increases the risk that their cancer could spread to the skin of their scalp (scalp skin metastases).
So far, studies looking at this have mostly been in people with breast cancer. But in general, the risk of scalp metastases (mets) is already quite low. No studies have shown that scalp cooling increases your risk for developing scalp mets any more than if you don’t use scalp cooling.
Concern about the cost of scalp cooling is the most common reason people don’t ask about or use it.
Medicare started covering scalp cooling in 2022 with a one-time benefit up to $1,850. This applies to automated scalp cooling systems, which are FDA-approved. Medicare might also cover certain supplies needed for scalp cooling, such as extra caps. Many insurance companies now also cover or reimburse for these systems.
Manual cold caps are not regulated or FDA-approved, so they may or may not be covered by insurance. Medicare does not cover manual cold caps.
If you are considering using scalp hypothermia (with a manual cap or an automatic cap), it’s important to carefully weigh the potential benefits, discomforts, and risks. Discuss the pros and cons with your cancer care team. You might also want to ask if your treatment center has experience using cooling caps and how successful they have been.
There are several resources available to people who can’t afford to pay for scalp cooling.
There are also many state and local organizations that offer financial assistance.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Giarratano T, Frezzini S, Zanocco M, et al. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study. Breast J 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31837103.
Medicare Coverage Database. Scalp cooling for the prevention of chemotherapy-induced alopecia. CMS.gov. July 2023. Accessed July 16th, 2024. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39572&ver=3
National Comprehensive Cancer Network. Breast Cancer. Version 4.2024. Updated July 3, 2024. Accessed July 17th, 2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
Rugo HS & Van Den Hurk, C. Alopecia related to systemic cancer therapy. UpToDate. UpToDate, Inc; 2024. Last updated August 3, 2023. Accessed June 26, 2024. https://www.uptodate.com/contents/alopecia-related-to-systemic-cancer-therapy
Shah VV, Wikramanayake TC, DelCanto GM, et al. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: A review of controlled clinical trials. J Eur Acad Dermatol Venereol. 2018;32(5):720-734.
Wikramanayake TC, Haberland NI, Akhundlu A, Laboy Nieves A, Miteva M. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming? Current Oncology. 2023; 30(4):3609-3626. https://doi.org/10.3390/curroncol30040275
Last Revised: September 5, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.